Trading Options with an Edge
Select Page

IMVT

Search by
TICKER SYMBOL

Immunovant Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

8.74

0.09

(1.04%)

Volume:

490,022

52 week range:

6.68 - 53.75

Market Cap:

1.005B

Company Description:

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.